Clinical Trials Browser

Completed × cemiplimab × Sarcoma × Clear all

NCT04873375 2024-10-31

Cemiplimab for Secondary Angiosarcomas

Phase 2 Completed

Hemangiosarcoma, Neoplasm Metastasis, Sarcoma

NCT02423863 2020-12-17

Poly-ICLC

Phase 2 Completed

DermatologicHead & NeckSarcoma

Head and Neck Neoplasms, Melanoma, Neoplasms, Sarcoma